"Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse

被引:10
作者
Bearn, Jenny [1 ,2 ]
O'Brien, Matthew [1 ]
机构
[1] South London & Maudsley NHS Fdn Trust, Addict Clin Acad Grp, London, England
[2] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
来源
NEUROPSYCHIATRIC COMPLICATIONS OF STIMULANT ABUSE | 2015年 / 120卷
关键词
GAMMA-HYDROXYBUTYRATE GHB; ECSTASY MDMA; BUTYROLACTONE GBL; KETAMINE USE; PATTERNS; ACID; ANTAGONIST; WITHDRAWAL; TOXICITY; FEATURES;
D O I
10.1016/bs.irn.2015.02.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Eating, drinking, sexual activity, and parenting invoke pleasure, an emotion that promotes repetition of these behaviors, are essential for survival. Euphoria, a feeling or state of intense excitement and happiness, is an amplification of pleasure, aspired to one's essential biological needs that are satisfied. People use party drugs as a shortcut to euphoria. Ecstasy (3,4-methylenedioxymethamphetamine), gamma-hydroxybutyric acid, and ketamine fall under the umbrella of the term "party drugs," each with differing neuropharmacological and physiological actions. This chapter seeks to survey the history and epidemiology of party drug use; we will then discuss the pharmacological characteristics of each drug to provide a platform for understanding the difficulties that party drug users encounter through intoxication, harmful use, dependence, and withdrawal and how these should be clinically managed.
引用
收藏
页码:205 / 233
页数:29
相关论文
共 105 条
  • [41] Gamma hydroxy butyrate abuse and dependency
    Gonzalez, A
    Nutt, DJ
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (02) : 195 - 204
  • [42] The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")
    Green, AR
    Mechan, AO
    Elliott, JM
    O'Shea, E
    Colado, MI
    [J]. PHARMACOLOGICAL REVIEWS, 2003, 55 (03) : 463 - 508
  • [43] Inadvertent ketamine overdose in children: Clinical manifestations and outcome
    Green, SM
    Clark, R
    Hostetler, MA
    Cohen, M
    Carlson, D
    Rothrock, SG
    [J]. ANNALS OF EMERGENCY MEDICINE, 1999, 34 (04) : 492 - 497
  • [44] SUBJECTIVE REPORTS OF THE EFFECTS OF MDMA IN A CLINICAL SETTING
    GREER, G
    TOLBERT, R
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 1986, 18 (04) : 319 - 327
  • [45] Greer G.R., 1985, ADVANCES, V2, P57
  • [46] Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management
    Hall, AP
    Henry, JA
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2006, 96 (06) : 678 - 685
  • [47] RELATIONSHIP OF STRUCTURE OF MESCALINE AND SEVEN ANALOGS TO TOXICITY AND BEHAVIOR IN 5 SPECIES OF LABORATORY-ANIMALS
    HARDMAN, HF
    HAAVIK, CO
    SEEVERS, MH
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1973, 25 (02) : 299 - 309
  • [48] Hashimoto K, 2014, EXPER OPIN THER TAR, P1
  • [49] Targeting of NMDA receptors in new treatments for schizophrenia
    Hashimoto, Kenji
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 1049 - 1063
  • [50] DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale
    Hasin, Deborah S.
    O'Brien, Charles P.
    Auriacombe, Marc
    Borges, Guilherme
    Bucholz, Kathleen
    Budney, Alan
    Compton, Wilson M.
    Crowley, Thomas
    Ling, Walter
    Petry, Nancy M.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (08) : 834 - 851